Announcements Trials

Browse Landscape

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Colorectal Cancer Metastatic × glucopyranosyl lipid-A × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Sarcoma 1 Melanoma 1 Colorectal Cancer Metastatic 1

Interventions

Bevacizumab 17 Capecitabine 13 Cetuximab 10 Oxaliplatin 8 Irinotecan 8 Fluorouracil 7 Panitumumab 5 Leucovorin 4 trifluridine tipiracil drug combination 3 sintilimab 3 regorafenib 3 Nivolumab 3 Ipilimumab 3 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 2 Folfox protocol 2 Drug Therapy 2 spartalizumab 1 pembrolizumab 1 irinotecan sucrosofate 1 glucopyranosyl lipid-A 1 folfirinox 1 camrelizumab 1 balstilimab 1 anisodamine 1 aflibercept 1 XELOX 1 Vemurafenib 1 Tyrosine Kinase Inhibitors 1 Transurethral Resection of Prostate 1 Tomography, X-Ray Computed 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03982121 2020-02-17

ISILI

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Withdrawn

Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡